Jennifer Bealer - 05 Nov 2021 Form 4 Insider Report for Progyny, Inc. (PGNY)

Signature
/s/ Jennifer Bealer
Issuer symbol
PGNY
Transactions as of
05 Nov 2021
Net transactions value
-$2,115,352
Form type
4
Filing time
09 Nov 2021, 19:57:52 UTC
Previous filing
27 Oct 2021
Next filing
22 Nov 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGNY Common Stock Sale $325,936 -5,041 -7% $64.66 66,590 05 Nov 2021 Direct F1
transaction PGNY Common Stock Sale $110,677 -1,700 -2.6% $65.10 64,890 05 Nov 2021 Direct F1, F2, F3
transaction PGNY Common Stock Sale $142,959 -2,157 -3.3% $66.28 62,733 05 Nov 2021 Direct F1, F3, F4
transaction PGNY Common Stock Sale $65,819 -981 -1.6% $67.09 61,752 05 Nov 2021 Direct F1, F3, F5
transaction PGNY Common Stock Sale $14,360 -211 -0.34% $68.06 61,541 05 Nov 2021 Direct F1, F3, F6
transaction PGNY Common Stock Award $0 +30,000 +49% $0.000000 91,541 08 Nov 2021 Direct F7
transaction PGNY Common Stock Sale $223,727 -3,463 -3.8% $64.60 88,078 08 Nov 2021 Direct F1, F3, F8
transaction PGNY Common Stock Sale $755,024 -11,499 -13% $65.66 76,579 08 Nov 2021 Direct F1, F3, F9
transaction PGNY Common Stock Sale $463,416 -6,963 -9.1% $66.55 69,616 08 Nov 2021 Direct F1, F3, F10
transaction PGNY Common Stock Sale $13,433 -200 -0.29% $67.16 69,416 08 Nov 2021 Direct F1, F3, F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGNY Employee Stock Option (Right to Buy) Award $0 +115,000 $0.000000 115,000 08 Nov 2021 Common Stock 115,000 $66.66 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 28, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.51 to $65.47, inclusive.
F3 The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2), (4), (5), (6), (8), (9), (10) and (11).
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.59 to $66.55, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.60 to $67.51, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.79 to $68.32, inclusive.
F7 Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.11 to $65.04, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.13 to $66.12, inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.15 to $67.12, inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.16 to $67.17, inclusive.
F12 One-fourth (1/4th) of the shares subject to the option will vest November 8, 2022 and the remainder of the shares will vest in equal quarterly installments thereafter through November 8, 2025, subject to the Reporting Person continuing to provide service through each such date.